Jazz Pharmaceuticals Fair Value
J7
The fair market value of J7Z.SW stock is 115.88 CHF. Relative to the market price of 0 CHF Jazz Pharmaceuticals is undervalued by 20.9%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Jazz Pharmaceuticals Valuation
The fair value level of 115.88 CHF can be considered as an effective entry point for long-term investors to start investing in J7Z.SW stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
J7Z.SW stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Jazz Pharmaceuticals PLC Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
102.28
2
Median P/E over 5 years
21.33
3
Minimum P/E over 5 years
16.14
4
Earning per share (last 12 months)
6.26 USD
Maximum value
1
x
4
=
555.56 CHF
Fair value
2
x
4
=
115.88 CHF
Minimum value
3
x
4
=
87.64 CHF
Jazz Pharmaceuticals PLC price metrics
-2.49
Annual return (geometric mean)
32.66
Risk (standard deviation) of returns
β
0.42
Beta (volatility compared to market)